Melissa Pirolli

549 total citations
16 papers, 365 citations indexed

About

Melissa Pirolli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Melissa Pirolli has authored 16 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 3 papers in Hematology. Recurrent topics in Melissa Pirolli's work include Bone health and treatments (7 papers), Cancer Diagnosis and Treatment (6 papers) and Medical Imaging and Pathology Studies (5 papers). Melissa Pirolli is often cited by papers focused on Bone health and treatments (7 papers), Cancer Diagnosis and Treatment (6 papers) and Medical Imaging and Pathology Studies (5 papers). Melissa Pirolli collaborates with scholars based in United States, Austria and Canada. Melissa Pirolli's co-authors include Alexander Liede, Rohini K. Hernandez, Sally Wade, Gary H. Lyman, Adam Reich, Rajul K. Jain, Lee S. Schwartzberg, W. SCOTT STRYKER, Victor M. Gastañaga and Jorge Arellano and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.

In The Last Decade

Melissa Pirolli

15 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melissa Pirolli United States 5 231 118 99 74 42 16 365
Joseph D. Kohles United States 11 244 1.1× 113 1.0× 66 0.7× 46 0.6× 86 2.0× 25 416
Changli Wang China 9 392 1.7× 71 0.6× 109 1.1× 29 0.4× 32 0.8× 16 475
Eun Ji Han South Korea 12 78 0.3× 129 1.1× 153 1.5× 178 2.4× 36 0.9× 46 425
Zhi‐Qing Long China 12 237 1.0× 70 0.6× 80 0.8× 37 0.5× 104 2.5× 30 483
Anastasia Xourafa Italy 12 77 0.3× 53 0.4× 38 0.4× 12 0.2× 49 1.2× 24 348
Andrea Ferraro Italy 11 72 0.3× 133 1.1× 275 2.8× 22 0.3× 25 0.6× 13 386
Roberto Adriano Latini Italy 9 27 0.1× 242 2.1× 56 0.6× 105 1.4× 64 1.5× 12 525
Xiaobo He China 7 412 1.8× 81 0.7× 215 2.2× 22 0.3× 79 1.9× 8 561
Christos Christopoulos United Kingdom 9 44 0.2× 104 0.9× 56 0.6× 24 0.3× 34 0.8× 17 280
Tsugio Eto Japan 7 191 0.8× 146 1.2× 162 1.6× 17 0.2× 37 0.9× 13 370

Countries citing papers authored by Melissa Pirolli

Since Specialization
Citations

This map shows the geographic impact of Melissa Pirolli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Pirolli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Pirolli more than expected).

Fields of papers citing papers by Melissa Pirolli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Pirolli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Pirolli. The network helps show where Melissa Pirolli may publish in the future.

Co-authorship network of co-authors of Melissa Pirolli

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Pirolli. A scholar is included among the top collaborators of Melissa Pirolli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Pirolli. Melissa Pirolli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hernandez, Rohini K., Sally Wade, Adam Reich, et al.. (2018). Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer. 18(1). 44–44. 246 indexed citations
2.
Hernandez, Rohini K., Sally Wade, Adam Reich, et al.. (2016). Incidence of bone metastases in U.S. patients with solid tumors.. Journal of Clinical Oncology. 34(15_suppl). e13099–e13099. 3 indexed citations
3.
4.
Gastañaga, Victor M., Lee S. Schwartzberg, Rajul K. Jain, et al.. (2016). Prevalence of hypercalcemia among cancer patients in the United States. Cancer Medicine. 5(8). 2091–2100. 61 indexed citations
5.
Hernandez, Rohini K., Karynsa Cetin, Melissa Pirolli, et al.. (2015). Estimating high-risk castration resistant prostate cancer (CRPC) using electronic health records.. PubMed. 22(4). 7858–64. 4 indexed citations
6.
Arellano, Jorge, Rohini K. Hernandez, Sally Wade, et al.. (2015). Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States. Cancer Medicine. 4(5). 713–720. 9 indexed citations
7.
Gastañaga, Victor M., L. Schwartzberg, Melissa Pirolli, et al.. (2015). 1030 Prevalence of hypercalcemia of malignancy and associated survival in the United States: Analyses from real-world electronic health records (EHR). European Journal of Cancer. 51. S155–S155. 1 indexed citations
8.
9.
Hernandez, Rohini K., et al.. (2014). Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States. Breast Cancer Research and Treatment. 146(3). 637–646. 1 indexed citations
10.
Hernandez, Rohini K., et al.. (2014). Validation of Bone Metastases Coding in an Oncology Electronic Medical Records Database and a Commercial Claims Database. Annals of Epidemiology. 24(9). 684–684. 4 indexed citations
11.
Chen, Kristina, et al.. (2013). Prevalence of renal insufficiency (RI) in cancer (Ca) patients (pts) with bone metastases (BM).. Journal of Clinical Oncology. 31(15_suppl). e12508–e12508. 2 indexed citations
12.
Pirker, Robert, et al.. (2012). Hemoglobin decline in cancer patients receiving chemotherapy without an erythropoiesis-stimulating agent. Supportive Care in Cancer. 21(4). 987–992. 14 indexed citations
13.
Liede, Alexander, et al.. (2012). Abstract P2-13-03: Prevalence of non-metastatic breast cancer patients treated with aromatase inhibitors in the United States. Cancer Research. 72(24_Supplement). P2–13. 1 indexed citations
14.
15.
Hess, Gregory P., et al.. (2008). Effect of changes in labeling and reimbursement on use of ESAs and transfusions. Journal of Clinical Oncology. 26(15_suppl). 20589–20589. 4 indexed citations
16.
Pirolli, Melissa. (2004). Optimization Techniques for Image Restoration. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph D. Kohles Breakdown of academic impact, for papers by Changli Wang Breakdown of academic impact, for papers by Eun Ji Han Breakdown of academic impact, for papers by Zhi‐Qing Long Breakdown of academic impact, for papers by Anastasia Xourafa Breakdown of academic impact, for papers by Andrea Ferraro Breakdown of academic impact, for papers by Roberto Adriano Latini Breakdown of academic impact, for papers by Xiaobo He Breakdown of academic impact, for papers by Christos Christopoulos Breakdown of academic impact, for papers by Tsugio Eto
Rankless by CCL
2026